Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JR-446 in Mucopolysaccharidosis Type IIIB
NCT07640984Phase 2Recruiting
- Sponsor
- JCR Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Jun 2028
- Countries
- 3
01
Overview
A Phase 2 trial of JR-446, sponsored by JCR Pharmaceuticals. Started Sep 2026; status: recruiting.
02
Drugs
JR-446
Beyond the preview
Go deeper on NCT07640984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640984.